204 related articles for article (PubMed ID: 17606927)
1. Insulin-like growth factor binding protein 2 promotes glioma development and progression.
Dunlap SM; Celestino J; Wang H; Jiang R; Holland EC; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11736-41. PubMed ID: 17606927
[TBL] [Abstract][Full Text] [Related]
2. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
Phillips LM; Zhou X; Cogdell DE; Chua CY; Huisinga A; R Hess K; Fuller GN; Zhang W
J Pathol; 2016 Jul; 239(3):355-64. PubMed ID: 27125842
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.
Holmes KM; Annala M; Chua CY; Dunlap SM; Liu Y; Hugen N; Moore LM; Cogdell D; Hu L; Nykter M; Hess K; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3475-80. PubMed ID: 22345562
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
[TBL] [Abstract][Full Text] [Related]
6. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
[TBL] [Abstract][Full Text] [Related]
7. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
8. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
[TBL] [Abstract][Full Text] [Related]
9. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.
Mendes KN; Wang GK; Fuller GN; Zhang W
Int J Oncol; 2010 Jul; 37(1):143-53. PubMed ID: 20514406
[TBL] [Abstract][Full Text] [Related]
10. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
12. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Sonoda Y; Ozawa T; Aldape KD; Deen DF; Berger MS; Pieper RO
Cancer Res; 2001 Sep; 61(18):6674-8. PubMed ID: 11559533
[TBL] [Abstract][Full Text] [Related]
13. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
14. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
[TBL] [Abstract][Full Text] [Related]
15. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
[TBL] [Abstract][Full Text] [Related]
16. IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.
Becher OJ; Peterson KM; Khatua S; Santi MR; MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1205-13. PubMed ID: 18952587
[TBL] [Abstract][Full Text] [Related]
17. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.
Sonoda Y; Ozawa T; Hirose Y; Aldape KD; McMahon M; Berger MS; Pieper RO
Cancer Res; 2001 Jul; 61(13):4956-60. PubMed ID: 11431323
[TBL] [Abstract][Full Text] [Related]
18. IGFBP2 promotes glioma tumor stem cell expansion and survival.
Hsieh D; Hsieh A; Stea B; Ellsworth R
Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
[TBL] [Abstract][Full Text] [Related]
19. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
20. Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs.
McQueeney K; Dealy CN
Growth Horm IGF Res; 2001 Dec; 11(6):346-63. PubMed ID: 11914022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
